U.S. Pharma Stock News

Over the last 7 days, the United States market has experienced a slight decline of 2.3%, although it has shown resilience with a 13% rise over the past year and an optimistic forecast of 16% annual earnings growth. In this dynamic environment, identifying stocks with strong potential often involves looking beyond well-known names to find those undiscovered gems that align with current growth trends and market conditions.

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In such a dynamic environment, selecting dividend stocks with reliable yields can provide stability and income potential for investors seeking to navigate market fluctuations.

Wondering whether Safety Insurance Group at around US$73.39 is a sensible entry or hold for you right now? This article focuses squarely on what the current price might imply about value. The stock has been fairly steady in the very short term with a 0.8% return over the last week. The past month shows a 6.4% decline and the year-to-date return sits at a 3.1% decline, alongside a 1.7% decline over the past year, a 14.6% return over three years and a 7.8% return over five years. Recent...

If you are wondering whether Helios Technologies at around US$67.54 is still attractively priced after a big run, the key question is what you are really paying for today. The stock has moved 4.0% over the last 7 days, sits on a year to date return of 23.5%, and has delivered 98.3% over the last year, although the past 30 days show a 9.0% decline that may have shifted perceptions of risk and opportunity. Recent coverage around Helios Technologies has focused on how its share price...

In March 2026, Compass Minerals International, Inc. completed the full redemption of the US$150,000,000 aggregate principal amount of its 6.750% Senior Notes due 2027 using cash on hand, paying 100% of principal plus accrued interest to the redemption date. This move marks an acceleration of the company’s balance sheet transformation and debt reduction efforts, which may enhance financial flexibility and lower interest costs. We’ll now examine how this accelerated debt redemption shapes...

Klaviyo (NYSE:KVYO) has launched Composer, an AI-driven agentic tool designed to build full marketing campaigns. The company also rolled out expanded Customer Agent capabilities and more than 75 new features across marketing, data, analytics, and customer service. These changes represent a broad update to Klaviyo's marketing automation platform, aimed at unifying workflows and customer data. Klaviyo operates in marketing automation and customer engagement, an area where brands are looking...

MongoDB (NasdaqGM:MDB) has appointed Ryan Mac Ban as Chief Revenue Officer. The new CRO is tasked with driving the next phase of growth in AI and cloud data markets. This leadership change follows other recent executive additions at the company. For investors watching MongoDB, the new CRO role sits at the center of how the company turns demand for AI and multi cloud data platforms into actual revenue. MongoDB focuses on modern database and developer data tools that are widely used in cloud...

Wondering whether Prosperity Bancshares at around US$66 is offering good value today, or if the price already reflects its strengths? This article breaks down what the numbers are really saying about the stock. The share price is around US$66.41 after a recent 2.9% gain over the last 7 days, set against a 9.7% decline over 30 days and a 4.6% decline year to date and over 1 year, with a 3 year return of 18.6% and 5 year return of 2.8%. Recent coverage has focused on how Prosperity Bancshares...

If you are wondering whether Ocugen's current share price still makes sense after a strong run, the key question is how that price lines up with the underlying value of the business. Ocugen shares, which last closed at US$1.92, have had a mixed but attention grabbing run, with a 21.6% decline over the last 7 days, a 20.0% gain over 30 days, 39.1% year to date, 168.6% over 1 year and 131.3% over 3 years, set against a 71.6% loss over 5 years. Recent news coverage has focused on Ocugen's...

Hesai Group (NasdaqGS:HSAI) has just posted its FY 2025 third quarter numbers, with revenue of C¥795.4 million and basic EPS of C¥1.88 setting the tone for the latest update. The company has seen quarterly revenue move from C¥458.9 million in Q2 2024 to C¥719.8 million in Q4 2024 and then to C¥795.4 million in Q3 2025. Basic EPS has shifted from a loss of C¥0.56 per share in Q2 2024 to C¥1.13 in Q4 2024 and C¥1.88 in Q3 2025, pointing to a business where margins are increasingly in focus for...

Last week's earnings announcement from Turtle Beach Corporation ( NASDAQ:TBCH ) was disappointing to investors, with a...

Wondering whether AppFolio at around US$161.05 still makes sense as an investment, or if the recent price puts it out of your comfort zone on value. The stock has seen a 4.4% decline over the last 7 days, a 6.5% decline over 30 days, and a 30.1% decline year to date and over 1 year, while the 3 year and 5 year returns sit at 34.0% and 16.5% respectively. Recent coverage has focused on how the year to date and 1 year share price performance of 30.1% may be influencing investor sentiment...

If you are wondering whether Merit Medical Systems at around US$67.55 is starting to look appealing or still feels expensive, the recent share performance gives you a useful starting point. The stock has seen a 3.8% decline over the last 7 days, a 17.8% fall over the last 30 days, and is down 21.9% year to date and 35.5% over the past year, while the 5 year return stands at 13.4%. These moves have put more attention on how the market currently prices Merit Medical Systems and whether...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

The recent 13% drop in Indaptus Therapeutics, Inc.'s ( NASDAQ:INDP ) stock could come as a blow to insiders who...

Over the last 7 days, the U.S. market has dropped by 2.3%, though it has shown a robust increase of 13% over the past year, with earnings projected to grow by 16% annually in the coming years. In such fluctuating conditions, identifying stocks with strong fundamentals and solid balance sheets can be crucial for investors seeking growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, continue to present underappreciated potential for growth and...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has shown resilience with a 13% rise over the past year and earnings are expected to grow by 16% annually. In such dynamic conditions, dividend stocks can offer investors stability and income potential, making them an attractive option for those seeking steady returns amidst market fluctuations.

Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...

Even if it's not a huge purchase, we think it was good to see that Douglas Reynolds, the President of Energy Services...

We feel now is a pretty good time to analyse CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) business as it appears...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

On March 10, Centrus Energy (NYSE:LEU) adopted amended bylaws addressing new universal proxy rules. The changes clarify shareholder voting standards and tighten requirements for using universal proxy cards in director elections. The board also updated exclusive forum provisions that govern where certain legal disputes must be brought. Centrus Energy is drawing fresh attention after its board revised the company bylaws to align with evolving proxy and legal frameworks. The move comes as the...

We wouldn't blame Viemed Healthcare, Inc. ( NASDAQ:VMD ) shareholders if they were a little worried about the fact that...